Metformin response based on genetic variation in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how your genes might affect the way your body responds to metformin, a common diabetes medication. It aims to see if a specific genetic variation influences treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You are between 18 and 65 years old
- You are not taking insulin or more than two diabetes medications
- You are not pregnant or breastfeeding
- You do not have HIV, cancer, or a rheumatic disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two common diabetes treatments – metformin and a natural supplement called berberine – to see which works better for people with a specific genetic type. If you qualify, you’ll receive one of these treatments to help control your blood sugar.
This study looks at how your genes affect your body's response to a diabetes medication called semaglutide. It may help people with slightly high blood sugar (pre-diabetes) understand why some respond better than others.
This study looks at how a specific gene change affects the body's ability to produce insulin. It may help doctors understand why some people are more likely to develop diabetes and could lead to better treatments.
This study looks at how certain genes affect the risk of type 2 diabetes and how well the drug exenatide (a GLP-1 receptor agonist) works in Chinese patients. It aims to see if your genetic makeup can predict how you will respond to treatment.
This study looks at how genetic risk relates to developing type 2 diabetes, using information from a biobank and body measurements like weight. It may help researchers better identify who is at higher risk before diabetes starts.
This study looks at genetic factors in people recently diagnosed with diabetes to understand what might predict who needs insulin treatment. Researchers will analyze blood samples and medical information to see if genetic testing could help doctors predict your treatment path.
Hear when a new Diabetes Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.